| Literature DB >> 25224018 |
Giovanni De Caridi1, Mafalda Massara1, Ignazio Acri1, Salvatore Zavettieri1, Raffaele Grande2, Lucia Butrico2, Stefano de Franciscis2,3, Raffaele Serra4,5.
Abstract
The aim of this study was to evaluate the results of treatment of venous lower limbs ulcers through the topical application of polynucleotides and hyaluronic acid gel (PNHA): Nucliaskin S™ (Mastelli srl, San Remo, Italy). This study was carried out in 39 consecutive patients who were randomly allocated to two groups: group I (20 patients) received treatment with PNHA (topical gel application two times a week, for a total of 6 weeks); group II (19 patients) received only hyaluronic acid (HA) topical application. All patients received a surgical debridement of the ulcerative lesions before topical treatment with PNHA or HA. Pre-treatment data indicated the area of ulceration. The number of healed ulcers and the variation in area of ulceration were considered as endpoints. The endpoints were observed after 45 days from the beginning of treatment. Complete wound healing occurred in 60% of limbs of group I and in 22% of those of group II patients. The average area reduction was 67% versus 34% in patients of group I and II, respectively. No side effects were recorded in both groups. Our experience shows that PNHA has an elevated trophic effect and speeds the healing rate of venous lower limb ulcers. This treatment may be a valid option in clinical practice.Entities:
Keywords: Hyaluronic acid; Lower limbs; PDRN; Polynucleotides; Venous ulcers
Mesh:
Substances:
Year: 2014 PMID: 25224018 PMCID: PMC7949893 DOI: 10.1111/iwj.12368
Source DB: PubMed Journal: Int Wound J ISSN: 1742-4801 Impact factor: 3.315